Avenue Therapeutics (ATXI) Q1 2026 Earnings

May 8Confirmed
Q1 2025
Q3 2025
Q4 2025
Q1 2026
-0.57
-0.45
-0.33
-0.21

Details

Expected EPS
N/A
Actual EPS
-0.21
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Avenue Therapeutics⁩ (⁦ATXI⁩) has reported earnings of ⁦-0.21⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts